<DOC>
	<DOCNO>NCT00182039</DOCNO>
	<brief_summary>This trial evaluate ability metoprolol ( beta-blocker drug ) prevent heart attack death around time surgery .</brief_summary>
	<brief_title>POISE Trial : Perioperative Ischemic Evaluation Study</brief_title>
	<detailed_description>The POISE Trial large multi-centre , blind , randomize control group trial metoprolol v placebo 10,000 risk patient undergoing noncardiac surgery . The POISE Trial determine impact perioperative administration metoprolol cardiovascular event ( define cardiovascular death , nonfatal myocardial infarction , nonfatal cardiac arrest ) 30 day post-operative period risk patient undergoing noncardiac surgery . Assuming control group event rate 6 % primary outcome , determine randomization 8000 patient would provide 85 % power 10,000 patient 92 % power detect relative risk reduction 25 % ( two-sided alpha = 0.05 ) . We set goal randomize 10,000 patient recognize would adequate power randomized 8000 patient . Without knowledge trial result know randomized 8000 patient higher predicted event rate , Operations Committee decide terminate recruitment July 31 , 2007 primarily remain study drug expire September 2007 .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Patients undergo noncardiac surgery ≥ 45 year age ; either sex . Have expect length stay ≥ 24 hour Fulfill one follow 6 criterion : coronary artery disease ; peripheral vascular disease ; history stroke due atherothrombotic disease ; hospitalization congestive heart failure within 3 year randomization ; undergo major vascular surgery ; OR 3 follow 7 criterion : schedule high risk surgery ( i.e . intraperitoneal intrathoracic ) ; emergency/urgent surgery ; history congestive heart failure ; history transient ischemic attack ( TIA ) ; diabetes currently oral hypoglycemic agent insulin therapy ; preoperative serum creatinine &gt; 175 µmol/L ( &gt; 2.0 mg/dl ) ; age &gt; 70 year . Contraindication metoprolol include follow : significant bradycardia ( heart rate &lt; 50 beat per minute ) ; second third degree heart block without pacemaker ; asthma active within last decade ; history chronic obstructive pulmonary disease ( COPD ) bronchospasm pulmonary function test . Clinical plan use betablocker preoperatively first 30 postoperative day Prior adverse reaction betablocker Coronary artery bypass graft ( CABG ) surgery complete revascularization precede 5 year evidence cardiac ischemia since CABG surgery Patients undergo low risk surgical procedure ( potential example include transurethral procedure [ transurethral prostatectomy ( TURPs ) , stone basket , etc . ] , ophthalmologic procedure topical regional anesthesia [ cornea transplant , cataract surgery , etc . ] , surgery limit physiological stress [ digital reimplantation , nerve repair , etc . ] ) Concurrent use verapamil Prior enrollment trial</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>randomize control trial</keyword>
	<keyword>blind</keyword>
	<keyword>noncardiac surgery</keyword>
	<keyword>cardiovascular event</keyword>
</DOC>